• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Radiol Med . Assessment of cerebrovascular disease with computed tomography in COVID-19 patients: correlation of a novel specific visual score with

tetano

Editor, Senior Moderator
Radiol Med


. 2020 Nov 28.
doi: 10.1007/s11547-020-01313-9. Online ahead of print.
Assessment of cerebrovascular disease with computed tomography in COVID-19 patients: correlation of a novel specific visual score with increased mortality risk


Andrea Bianchi[SUP] 1 [/SUP], Lorenzo Nicola Mazzoni[SUP] 2 3 [/SUP], Simone Busoni[SUP] 2 [/SUP], Nicola Pinna[SUP] 1 4 [/SUP], Marco Albanesi[SUP] 4 5 [/SUP], Edoardo Cavigli[SUP] 5 [/SUP], Diletta Cozzi[SUP] 6 [/SUP], Anna Poggesi[SUP] 7 8 [/SUP], Vittorio Miele[SUP] 5 [/SUP], Enrico Fainardi[SUP] 1 9 [/SUP], Davide Gadda[SUP] 1 [/SUP]



Affiliations

Abstract

Purpose: Cerebrovascular disease (CVD) is considered a major risk factor for fatal outcome in COVID-19. We aimed to evaluate the possible association between computed tomography (CT) signs of chronic CVD and mortality in infected patients.
Materials and methods: We performed a double-blind retrospective evaluation of the cerebral CT scans of 83 COVID-19 patients looking for CT signs of chronic CVD. We developed a rapid visual score, named CVD-CT, which summarized the possible presence of parietal calcifications and dolichosis, with or without ectasia, of intracranial arteries, areas of chronic infarction and leukoaraiosis. Statistical analysis was carried out with weighted Cohen's K test for inter-reader agreement and logistic regression to evaluate the association of in-hospital mortality with CVD-CT, chest X-ray (CXR) severity score (Radiographic Assessment of Lung Edema-RALE) for radiological assessment of pulmonary disease, sex and age.
Results: CVD-CT (odds ratio 1.6, 95% C.I. 1.2-2.1, p = 0.001) was associated with increased risk of mortality. RALE showed an almost significant association (odds ratio 1.05, 95% C.I. 1-1.1, p 0.06), whereas age and sex did not.
Conclusion: CVD-CT is associated with risk of mortality in COVID-19 patients. The presence of CT signs of chronic CVD may be correlated to a condition of fragility of the circulatory system, which constitutes a key risk factor for death in infected patients.

Keywords: CT; Cerebrovascular disease; Coronavirus disease; Mortality; Risk factor.
 
Back
Top Bottom